MoneyWorks4Me

Biocon - Quaterly Results

23 May 2023 Evaluate
Revenue reduced marginally to stand at Rs. 5067.00 millions during the quarter ended March 2023. The figure stood at Rs. 5177.00 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 4652.76% to Rs. 18108.00  millions  from Rs. 381.00 millions in previous same quarter.The Operating Profit of the company witnessed a decrease to 200.00 millions from 873.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 5067.00 5177.00 -2.12 19929.00 17382.00 14.65 19929.00 17382.00 14.65
Other Income 640.00 608.00 5.26 2714.00 1872.00 44.98 2714.00 1872.00 44.98
PBIDT 200.00 873.00 -77.09 2949.00 2483.00 18.77 2949.00 2483.00 18.77
Interest 481.00 0.00 0.00 696.00 4.00 17300.00 696.00 4.00 17300.00
PBDT 18255.00 873.00 1991.07 30881.00 2479.00 1145.70 30881.00 2479.00 1145.70
Depreciation 294.00 281.00 4.63 1169.00 1082.00 8.04 1169.00 1082.00 8.04
PBT 17961.00 592.00 2933.95 29712.00 1397.00 2026.84 29712.00 1397.00 2026.84
TAX -147.00 211.00 -169.67 1228.00 536.00 129.10 1228.00 536.00 129.10
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 18108.00 381.00 4652.76 28484.00 861.00 3208.25 28484.00 861.00 3208.25
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 3.95 16.86 -76.59 14.80 14.28 3.59 14.80 14.28 3.59
Peers
Company Name CMP
Sun Pharma. Inds. 1784.25
Dr. Reddys Labs. 1197.35
Cipla 1335.60
Lupin 2012.00
Zydus Lifesciences 1141.00
View more..